Page 78 - Clinical Olfactory Working Group Consensus Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical olfactory working group consensus statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Olfactory Working Group Consensus Statement Today - Breaking & Trending Today

Kazakhstan's subunit COVID-19 vaccine ready for clinical trials – Health Ministry


14 April 2021 14:40
Share in:
NUR-SULTAN. KAZINFORM – The subunit vaccine against COVID-19 developed by Kazakhstani scientists is ready for clinical trials, Kazinform correspondent reports.
Related news
Vice-Minister of Education and Science Miras Daulenov, several COVID-19 vaccines are being developed at the Research Institute for Biological Safety Problems, including the subunit (recombinant) vaccine, which is ready to enter clinical trials. The trials will begin after the authorization of the Health Ministry.
According to him, the Institute is also working on a polyvalent vaccine, with the British and South African variants being closely studied for updating vaccines.
Notably, the Research Institute for Biological Safety Problems is developing five COVID-19 vaccines, including the inactive QazCOVID-in vaccine, two vector vaccines, an attenuated vaccine and a subunit vaccine. ....

South Africa , United Kingdom , South African , Miras Daulenov , Research Institute For Biological Safety Problems , Health Ministry , Science Miras Daulenov , Research Institute , Biological Safety Problems , Covid 19 , Clinical Trials , Kazakhstan S , Sub Unit , ஒன்றுபட்டது கிஂக்டம் , ஆராய்ச்சி நிறுவனம் க்கு உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ் , ஆரோக்கியம் அமைச்சகம் , ஆராய்ச்சி நிறுவனம் , உயிரியல் பாதுகாப்பு ப்ராப்லம்ஸ் , மருத்துவ சோதனைகள் , காஸக்ஸ்டாந் கள் , துணை அலகு ,

Welcome To IANS Live - LatestNews - Moderna Covid jab efficacy marginally drops to 90% in US trial


Photo Credit: IANS
IANSLive
New York, April 14 (IANS) Updated results from an ongoing Phase 3 clinical trial in the US have shown Moderna s Covid-19 vaccine to be 90 per cent effective against all cases of the disease, and greater than 95 per cent against severe cases.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 14-April-2021 ....

New York , United States , Moderna Covid , News Service , India Private , All Rights , 0 S , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் ,